Ljubljana – Slovenia’s national medical ethics committee has no reservations towards Lagevrio, a medicine also known as molnupiravir. The committee maintains that the drug brings significant progress in fighting the coronavirus epidemic, as it prevents a severe course of Covid-19 or death. The European Medicines Agency (EMA) recommended the drug for coronavirus treatment on 19 November even if it is not yet registered. The oral anti-viral drug, being developed by Merck Sharp & Dohme in collaboration with Ridgeback Biotherapeutics, is intended for the treatment of Covid-19 in adults. The EMA…
Latest
Most Popular
Slovenia’s Stance on Cryptocurrency and Digital Euro
Today, Slovenia is well-recognized, particularly in Europe as a haven for innovations, technological advancements, and progressive thinking. This environment has enabled Slovenia, one of...
Cryptocurrency Tax in Slovenia
When amateur investors start trading with cryptocurrencies and making profits turns into a business, tax standards come into effect in this area as well.Status...
The Blockchain Industry in Slovenia
Slovenia, though small, is one of the fastest-growing countries in Europe, particularly in the business and economic contexts. After its successful economic succession from...